KMC Speciality Hospitals (India) Ltd (KMCSHIL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by KMC Speciality Hospitals (India) Ltd on NSE and BSE, with an AI summary of each filing.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 14, 2026 for Sri Kauvery ....
Encumbered Shares - Invocation / Release · 14 Oct 2026, 9:33 pm
KMC Speciality Hospitals Discloses Revised Promoter Share Encumbrances KMC Speciality Hospitals (India) Ltd submitted revised SEBI SAST disclosures on 14th Oct'26, addressing BSE queries regarding indirect share encumbrances created by holding company Sri Kauvery Medical Care (India) Ltd (SKMCIL). SKMCIL holds a 75.00% stake in the target company. The revisions clarify indirect encumbrances over SKMCIL's equity shares securing NCDs issued by Prospera Healthcorp to lenders via Catalyst Trusteeship Ltd. Following transactions on 4th Aug'26 and 4th Sep'26, cumulative indirect encumbrances over SKMCIL reached 52.30% (2,66,84,582 shares), comprising share pledges and non-disposal undertakings.
We enclose herewith the Voting Results along with the Scrutinizer''s Report for the 43rd AGM of the Company held on September 28, 2026.
Annual General Meeting · 30 Sept 2026, 10:49 pm
The Summary of Proceedings of the 43rd Annual General Meeting of the Company held today i.e., September 28, 2026 through VC/ OAVM is enclosed herewith.
Annual General Meeting · 28 Sept 2026, 11:18 pm
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2026 for Sri Kauvery ....
Encumbered Shares - Invocation / Release · 15 Sept 2026, 11:42 pm
KMC Speciality Hospitals Discloses Promoter Indirect Encumbrance Clarifications Sri Kauvery Medical Care (India) Limited (SKMCIL), holding 75% in KMC Speciality Hospitals (India) Limited, submitted revised SEBI SAST disclosures on 15th Sep'26 following BSE queries. Clarifications confirm indirect encumbrances created on 4th Aug'26 in favour of Catalyst Trusteeship Limited for debentures issued by Prospera Healthcorp Private Limited. Encumbrances comprise a pledge over 74,10,831 equity shares (14.53% of SKMCIL) and a non-disposal undertaking on 1,65,32,316 shares (32.40% of SKMCIL). No direct encumbrance exists on KMC Speciality Hospitals shares.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2026 for Sri Kauvery Medical ....
Encumbered Shares - Invocation / Release · 15 Sept 2026, 11:20 pm
KMC Speciality Hospitals: Promoter Pledges Shares to Secure NCD Credit Facility Sri Kauvery Medical Care (India) Limited (SKMCIL), promoter holding 75% (12.23 cr shares) in KMC Speciality Hospitals (India) Limited, disclosed an indirect encumbrance created on 4th Sep'26. Certain shareholders of SKMCIL pledged 27,41,435 shares (5.37% of SKMCIL's equity) in favor of Catalyst Trusteeship Limited. The pledge secures non-convertible debentures issued by Prospera Healthcorp Private Limited under a trust deed dated 6th Jul'26. Consequently, total encumbered promoter holding increased from 14.53% (74.11 lakh shares) to 19.90% (1.02 cr shares) of SKMCIL's share capital.
A copy of the Business Responsibility and Sustainability Report for FY 2025-26 is enclosed.
Others (Uncategorized) · 03 Sept 2026, 11:31 pm
KMC Speciality Hospitals FY26 BRSR: Rs. 305.77 Cr Turnover and Strong ESG Execution For FY26, KMC Speciality Hospitals posted a turnover of Rs. 305.77 crore and a net worth of Rs. 210.43 crore across its two Trichy-based units. Highlighting strong ESG execution, renewable energy usage reached 92%, targeting 100% by FY27. The firm employs 1,742 staff, featuring a significant 77% female representation. Risk mitigation is underscored by the Maa Kauvery unit's LEED Silver rating and the Cantonment unit's ISO 27001:2022 data security certification. Zero regulatory penalties and robust waste management frameworks further insulate the operations from compliance risks.
In terms of Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 a copy of the Annual Report of the Company for the Financial year 2025-26 along ....
Others (Uncategorized) · 03 Sept 2026, 11:28 pm
A copy of the Notice of the 43rd AGM is enclosed.
Annual General Meeting · 03 Sept 2026, 11:08 pm
Investor presentation for the quarter ended 30th June, 2026
Investor Presentation · 28 Aug 2026, 9:49 pm
KMC Speciality Hospitals: Robust Q1 FY'27 Driven by Volume Growth and Margin Expansion KMC Speciality Hospitals reported strong Q1 FY'27 results, with total income rising 39% YoY to INR 93.6 Cr. EBITDA grew 76% YoY to INR 30.3 Cr, with margins expanding to 32.4% from 25.6%. PAT surged 120% YoY to INR 16.6 Cr, lifting PAT margin to 17.7%. Performance was driven by a 25% YoY increase in occupied bed days and an 11% rise in blended ARPOB to INR 34,214. Occupancy rate improved significantly to 86% from 69% in Q1 FY'26.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015: (i) Intimation of approval of new capacity expansion/ hospital projects at Trichy and Bengaluru; & (ii) Appointment of Cost Auditor
Change in Auditor · 14 Aug 2026, 5:21 pm
KMC Speciality Hospitals Announces Major Capacity Expansion in Trichy and Bengaluru The Board has approved a Rs. 519 crore capacity expansion, adding ~591 beds. A major Rs. 486 crore project in Trichy will add ~500 beds in two phases, commissioning in Q4 FY28 and Q2 FY30. This includes a new Super-Speciality Block (~400 beds) and expanding the Mother & Child Hospital (~100 beds). A new Rs. 33 crore, 91-bed asset-light Mother & Child hospital in Bengaluru is slated for Q2 FY28. The entire expansion will be funded via internal accruals and debt.
Please find enclosed the Standalone Unaudited Financial results for the quarter ended 30th June, 2026 along with the Limited Review Report of the Statutory Auditors as approved by the Board ....
Financial Result · 14 Aug 2026, 5:08 pm
KMC Speciality Hospitals (India) Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 9,178 (+37.9% YoY | +11.6% QoQ) ■ EBITDA: 2,849 (+73.1% YoY | +10.1% QoQ) ■ EBITDA Margin (%): 31.0 (+632 bps YoY | -42 bps QoQ) ■ PAT: 1,657 (+119.9% YoY | +13.3% QoQ) ■ EPS (INR): 1.02 (+121.7% YoY | +13.3% QoQ)
Please find enclosed the Standalone Unaudited Financial results for the Quarter ended 30th June, 2026 along with the Limited Review Report of the Statutory Auditors as approved by the Board ....
Outcome · 14 Aug 2026, 5:03 pm
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition/ Disposal of Shares · 12 Aug 2026, 4:29 pm
Indirect Encumbrance on KMC Speciality via Holding Company Share Pledge On 11th Aug'26, Catalyst Trusteeship disclosed an indirect encumbrance on KMC Speciality Hospitals. This arises from actions at its holding company, Sri Kauvery Medical Care (SKMCIL), where KMC is a 75% subsidiary. To secure debentures issued by Prospera Healthcorp, SKMCIL promoters pledged 14.53% of their shareholding and created a non-disposal undertaking over another 32.40%. This encumbers a total of 46.93% of SKMCIL's shares, creating an indirect charge over KMC Speciality Hospitals' assets. The pledge was executed on 07th Jul'26.
KMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve The unaudited ....
Intimation · 14 Aug 2026, 5:30 am
KMC Speciality Hospitals Board Meeting Set for Aug'26 to Approve Q1FY27 Results KMC Speciality Hospitals (India) Ltd (KMCSHIL) has scheduled a Board of Directors meeting for 14th Aug'26. The primary agenda is to consider and approve the company's unaudited financial results for the first quarter ending 30th Jun'26. This announcement, made pursuant to SEBI's Regulation 29, provides a key date for investors awaiting the company's Q1FY27 performance update.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 05, 2026 for Sri Kauvery Medical ....
Encumbered Shares - Invocation / Release · 05 Aug 2026, 8:05 pm
Promoter SKMCIL Creates Indirect Encumbrance on its Holding in KMC Speciality Hospitals On 05 Aug'26, Sri Kauvery Medical Care (India) Ltd (SKMCIL), promoter of KMC Speciality Hospitals, disclosed the creation of an indirect encumbrance. This secures non-convertible debentures to be issued by Prospera Healthcorp. The encumbrance includes a pledge over 74,10,831 SKMCIL shares (14.53%) and a non-disposal undertaking over 1,65,32,316 SKMCIL shares (32.40%) in favour of Catalyst Trusteeship. SKMCIL holds a 75% stake in KMC Speciality Hospitals. The encumbrance is on the promoter's shares, not directly on the target company's shares.
Investor Presentation for the quarter and year ended 31st March, 2026
Investor Presentation · 05 Jun 2026, 9:18 pm
KMC Speciality Hospitals Q4 FY'26 Results: Strong Growth in Revenue and Profitability KMC Speciality Hospitals reported robust Q4 FY'26 results with total income growing 36% YoY to INR 84.2 Cr. EBITDA surged 71% YoY to INR 27.8 Cr, with margins expanding significantly to 33.0% from 26.3%. PAT grew an impressive 225% YoY to INR 14.6 Cr, boosting PAT margin to 17.4% from 7.3%. Operational metrics showed strength, with occupied bed days up 24% and blended ARPOB increasing 7% YoY to INR 32,838. For FY'26, PAT grew 118% YoY to INR 46.7 Cr.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Purchase of vacant land by the Company
Others (Uncategorized) · 29 May 2026, 5:26 pm
Kauvery Hospital to Expand Tiruchirapalli Facility with Land Acquisition KMC Speciality Hospitals (India) Ltd announced on 29th May'26 its Board approved purchasing a 1-acre land parcel adjacent to its existing hospital in Tiruchirapalli, Tamil Nadu. The acquisition, valued at an estimated Rs. 62.50 crores, will be funded via internal accruals and debt. This strategic purchase supports future expansion plans, facilitating the addition of approximately 300 beds to its current infrastructure. The company confirmed it is not a related party transaction, signaling a key step in its organic growth strategy.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Appointment of Internal Auditor for FY 2026-27
Change in Management · 29 May 2026, 5:23 pm
KMC Speciality Hospitals Appoints Grant Thornton Bharat as Internal Auditor KMC Speciality Hospitals (India) Ltd announced that its Board of Directors, in a meeting on 29th May'26, approved the appointment of M/s. Grant Thornton Bharat LLP as the company's Internal Auditor. The appointment is for the fiscal year 2026-27. This move engages a prominent professional services firm with extensive global and domestic presence to oversee the company's internal financial controls and processes. No relationships between the appointee and the company's directors were disclosed.
Please find enclosed the Standalone Audited Financial Results for the FY 2025-26
Financial Result · 29 May 2026, 5:19 pm
KMC Speciality Hospitals FY26 Net Profit More Than Doubles to ₹467.3 Crore KMC Speciality Hospitals reported a strong financial performance for the year ended 31st Mar'26. Annual PAT grew 118.1% YoY to ₹467.3 cr from ₹214.3 cr, while revenue from operations increased 32.0% YoY to ₹3,057.7 cr. For Q4FY26, PAT surged 223.5% YoY to ₹146.3 cr on revenue of ₹822.5 cr, up 35.0% YoY. The Board approved the results on 29th May'26, which included an unmodified opinion from the auditor, Deloitte Haskins & Sells. Annualised EPS for FY26 stood at ₹2.87.
Please find enclosed the Standalone Audited Financial results for the Quarter and Year ended 31st March, 2026 along with the Auditors Report as approved by the Board of Directors at their ....
Outcome · 29 May 2026, 5:11 pm
KMC Speciality Hospitals (India) Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 8,225 (+35.0% YoY | +0.2% QoQ) ■ EBITDA: 2,587 (+67.9% YoY | +4.5% QoQ) ■ EBITDA Margin (%): 31.5 (+616 bps YoY | +129 bps QoQ) ■ PAT: 1,463 (+223.5% YoY | +6.6% QoQ) ■ EPS (INR): 0.90 (+233.3% YoY | +7.1% QoQ)
KMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve The Audited ....
Intimation · 29 May 2026, 5:30 am
KMC Speciality Hospitals Board to Review Q4 & FY26 Financial Results on May 29 KMC Speciality Hospitals (India) Ltd (BSE: 524520) has scheduled a Board of Directors meeting for Fri, 29th May'26. The primary agenda is to consider and approve the audited financial results for the quarter and financial year ended 31st Mar'26. This meeting will formalize the company's financial performance for Q4 and the full fiscal year 2026.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 17 Apr 2026, 9:18 pm
KMCSHIL Not Classified as a Large Corporate for FY26 KMC Speciality Hospitals (India) Ltd. (KMCSHIL) has confirmed it does not meet the criteria to be classified as a 'Large Corporate' as of 31 Mar '26, per SEBI circulars. Consequently, the mandatory borrowing and disclosure requirements for Large Corporates are not applicable to the company for the financial year ending 31 Mar '26. The filing on 17 Apr '26 also noted the company's outstanding borrowing was ₹71.35 Cr and its highest credit rating in the previous fiscal year was AA-.
Investor Presentation for the quarter and nine months ended December 31, 2025
Investor Presentation · 28 Mar 2026, 9:55 pm
KMC Speciality Hospitals Q3 FY'26 Results: Robust Growth in Revenue and Profitability KMC Speciality Hospitals reported strong Q3 FY'26 results with total income growing 33% YoY to INR 83.2 Cr. EBITDA surged 50% YoY to INR 25.9 Cr, with margins expanding to 31.1% from 27.5%. PAT increased 83% YoY to INR 13.7 Cr, lifting the PAT margin to 16.5% from 12.0%. Operational metrics showed positive trends, with occupied bed days up 11% and blended ARPOB increasing 17% YoY to INR 32,710. Occupancy rate for the quarter improved to 82% from 74% a year prior.
Intimation of Revision in Credit Rating
Others (Uncategorized) · 19 Mar 2026, 11:32 pm
KMC Speciality Hospitals (KMCSHIL) Receives Long-Term Rating Upgrade from India Ratings India Ratings & Research has upgraded KMC Speciality Hospitals' long-term rating for its bank loan facilities to IND AA-/Stable from IND A+/Positive on 18 Mar'26. The upgraded rating applies to term loan facilities totaling INR 768.15 million, reduced from INR 892.90 million. The short-term rating for its INR 10.00 million working capital facility was affirmed at IND A1+. This upgrade signals an improved credit profile and financial stability for the company.
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Giving Corporate Guarantee/Security.
Others (Uncategorized) · 11 Feb 2026, 5:19 pm
KMC Speciality Hospitals Provides Corporate Guarantee for Holding Company Loan KMC Speciality Hospitals (India) Ltd. announced on 11th Feb'26 it is providing a corporate guarantee for up to ₹98.57 Crs to State Bank of India. This guarantee secures a loan availed by its holding company, Sri Kauvery Medical Care (India) Limited. The amount represents 60% of KMC's tangible net worth as on 31st Mar'25. The transaction, conducted at arm's length, received shareholder approval on 28th Sep'20. The company stated there is no expected financial impact from this guarantee at present.